Collection 

Novel Theranostics

Submission status
Open
Submission deadline

In recent years, there has been a growing interest in the field of novel theranostics, which encompasses both Positron emission tomography (PET) imaging and radionuclide therapy. Theranostics aims to integrate diagnostic and therapeutic approaches to personalize patient care. PET imaging plays a crucial role in the diagnostics by enabling the visualization and characterization of specific biological targets and pathways relevant to disease pathology. Moreover, PET allows for the evaluation of novel radiotracers designed to target these biological markers, facilitating the development and optimization of targeted therapies.

This collection seeks submissions of original research from researchers and clinicians actively involved in applying PET imaging techniques with novel biological targets and radiotracers, as well as from scientists working on the development of new radiotracers for PET.

Submit manuscript
Submission guidelines
Manuscript editing services
CT scan an advance technology for medical diagnosis of heart

Editors

Articles will be displayed here once they are published.